Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
8.97
+0.25 (2.87%)
Nov 5, 2024, 1:19 PM EST - Market open
Arcutis Biotherapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 5, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 1,049 | 305 | 901 | 1,043 | 1,225 | - | |
Market Cap Growth | 83.92% | -66.18% | -13.58% | -14.88% | - | - | |
Enterprise Value | 864 | 283 | 626 | 681 | 1,039 | - | |
Last Close Price | 8.72 | 3.23 | 14.80 | 20.74 | 28.13 | - | |
PE Ratio | - | -0.85 | -2.62 | -4.97 | -7.40 | - | |
PS Ratio | 6.42 | 5.11 | 244.56 | - | - | - | |
PB Ratio | 5.45 | 3.44 | 4.30 | 3.50 | 4.53 | - | |
P/FCF Ratio | -6.08 | -1.23 | -3.49 | -5.94 | -10.81 | - | |
P/OCF Ratio | -6.08 | -1.23 | -3.50 | -5.97 | -10.84 | - | |
EV/Sales Ratio | 6.55 | 4.74 | 169.88 | - | - | - | |
EV/EBITDA Ratio | -4.93 | -1.18 | -2.08 | -3.31 | -7.61 | - | |
EV/EBIT Ratio | -4.89 | -1.17 | -2.08 | -3.30 | -7.61 | - | |
EV/FCF Ratio | -4.97 | -1.14 | -2.43 | -3.88 | -9.17 | - | |
Debt / Equity Ratio | 1.11 | 2.32 | 0.97 | 0.26 | 0.02 | 0.00 | |
Debt / FCF Ratio | -1.17 | -0.83 | -0.78 | -0.44 | -0.04 | -0.01 | |
Asset Turnover | 0.35 | 0.15 | 0.01 | - | - | - | |
Inventory Turnover | 0.83 | 0.48 | - | - | - | - | |
Quick Ratio | 7.90 | 6.38 | 11.06 | 11.61 | 12.61 | 19.36 | |
Current Ratio | 8.46 | 7.08 | 11.57 | 12.09 | 12.96 | 20.33 | |
Return on Equity (ROE) | -148.92% | -175.79% | -122.80% | -72.62% | -72.93% | -56.10% | |
Return on Assets (ROA) | -29.36% | -38.12% | -43.97% | -36.54% | -42.15% | -34.10% | |
Return on Capital (ROIC) | -33.11% | -42.65% | -47.89% | -39.67% | -45.26% | -35.94% | |
Earnings Yield | -19.50% | -85.99% | -34.55% | -19.78% | -11.07% | - | |
FCF Yield | -17.37% | -81.18% | -28.63% | -16.84% | -9.25% | - | |
Buyback Yield / Dilution | -61.61% | -25.94% | -11.39% | -38.51% | -1835.11% | -48.68% | |
Total Shareholder Return | -61.61% | -25.94% | -11.39% | -38.51% | -1835.11% | -48.68% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.